CRP and atherosclerosis: C reactive protein (CRP), a circulating inflammatory marker, has a controversial role in the atherosclerotic disease, but it can transform oxidized LDLc into foam cells and can be a stable biomarker for low-grade inflammation, especially found in subclinical atherosclerosis.